Compliance Rate

Compliance Rate 51.23%
Compliant submissions 187
Incompliant submissions 178
Total trials 365

My Organizations' Clinical Trials

Showing 1700 of 2400 entries
View as:

First-in-Human Clinical Trial of a Mosaic Quadrivalent Influenza Vaccine Compared With a Licensed Inactivated Seasonal QIV in Healthy Adults

Phase: N/A Priority: Normal
NCT ID: NCT04896086 Org: User:
Start: 05/24/21 End: 01/25/24 Due: 01/25/25

A Study of Pentamidine in the Prevention of Pneumocystis Carinii Pneumonia (PCP) in HIV-Infected Children Who Cannot Take Trimethoprim-Sulfamethoxazole

Phase: N/A Priority: Normal
NCT ID: NCT00001027 Org: User:
Start: - End: 09/30/96 Due: 09/30/97

Phase I Study of APL 400-003, a Candidate HIV Vaccine, in HIV-Negative Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT00001538 Org: User:
Start: 03/31/96 End: 04/30/01 Due: 04/30/02

Immunopathogenesis of Food Allergy and Eosinophilic Gastrointestinal Disorders

Phase: N/A Priority: Normal
NCT ID: NCT01212016 Org: User:
Start: 08/30/10 End: 05/13/15 Due: 05/13/16

Study of the Safety and Immunogenicity of Pfs230D1M-EPA/Alhydrogel and Pfs25M-EPA/Alhydrogel , a Transmission Blocking Vaccine Against Plasmodium Falciparum Malaria, in Adults in the U.S. and Mali

Phase: N/A Priority: Normal
NCT ID: NCT02334462 Org: User:
Start: 01/07/15 End: 10/22/18 Due: 10/22/19

Urinary Schistosomiasis Infection

Phase: N/A Priority: Normal
NCT ID: NCT00138450 Org: User:
Start: - End: 11/30/04 Due: 11/30/05

Therapeutic HIV Vaccine and Interleukin-2 to Increase the Immune System's Response to HIV

Phase: N/A Priority: Normal
NCT ID: NCT00056797 Org: User:
Start: 03/31/02 End: 03/31/06 Due: 03/31/07

Study of the Plasmodium Vivax Transmission-blocking Vaccine Pvs230D1-EPA/Matrix-M to Assess Safety, Immunogenicity, and Transmission-blocking Activity in Healthy Malaria-naive Adults

Phase: N/A Priority: Normal
NCT ID: NCT05913973 Org: User:
Start: 08/04/23 End: 11/03/25 Due: 11/03/26

Rheumatic Heart Disease Prevalence in Leon, Nicaragua

Phase: N/A Priority: Normal
NCT ID: NCT00307112 Org: User:
Start: 07/13/06 End: 11/28/08 Due: 11/28/09

Evaluating Heterologous-Insert Prime-Boost HIV Vaccine Regimens in HIV-Uninfected Adults

Phase: N/A Priority: Normal
NCT ID: NCT01095224 Org: User:
Start: 09/30/10 End: 02/29/16 Due: 02/28/17

The Impact of HAART on Response to Hepatitis C Treatment in Patients Taking Peginterferon Alpha-2b and Ribavirin

Phase: N/A Priority: Normal
NCT ID: NCT00031343 Org: User:
Start: 02/28/02 End: 04/30/04 Due: 04/30/05

Comparison of Treatments to Maintain Disease Remission in Patients With Wegener's Granulomatosis and Related Vasculitis Syndromes

Phase: N/A Priority: Normal
NCT ID: NCT00004567 Org: User:
Start: 02/29/00 End: 06/30/04 Due: 06/30/05

Safety and Immunogenicity of Pfs25M-EPA/AS01 and Pfs230D1M-EPA/AS01 Vaccines, Transmission Blocking Vaccines Against Plasmodium Falciparum, at Full and Fractional Dosing in Adults in Mali

Phase: N/A Priority: Normal
NCT ID: NCT02942277 Org: User:
Start: 10/21/16 End: 07/15/20 Due: 07/15/21

Safety and Immunogenicity of an Epstein-Barr Virus (EBV) gp350-Ferritin Nanoparticle Vaccine in Healthy Adults With or Without EBV Infection

Phase: N/A Priority: Normal
NCT ID: NCT04645147 Org: User:
Start: 03/29/22 End: 07/01/25 Due: 07/01/26

A Study of Two Adherence Plans to Help HIV-Positive Patients Take Their Medications Correctly

Phase: N/A Priority: Normal
NCT ID: NCT00001129 Org: User:
Start: - End: 06/30/03 Due: 06/30/04

VRC-HIVMAB060-00-AB (VRC01) in People With Chronic HIV Infection Undergoing Analytical Treatment Interruption

Phase: N/A Priority: Normal
NCT ID: NCT02471326 Org: User:
Start: 07/13/15 End: 04/07/17 Due: 04/07/18

Urban Environmental Factors and Childhood Asthma

Phase: N/A Priority: Normal
NCT ID: NCT00114881 Org: User:
Start: 02/02/05 End: 08/31/24 Due: 08/31/25

H5 Adult - Chiron Study of Bird Flu Vaccine

Phase: N/A Priority: Normal
NCT ID: NCT00280033 Org: User:
Start: 02/28/06 End: 11/30/06 Due: 11/30/07

Minocycline Pharmacokinetics (ACUMIN)

Phase: N/A Priority: Normal
NCT ID: NCT03369951 Org: User:
Start: 03/28/18 End: 07/20/19 Due: 07/20/20

Malaria Prevalence in Children

Phase: N/A Priority: Normal
NCT ID: NCT00322816 Org: User:
Start: 06/07/06 End: 03/31/09 Due: 03/31/10

HIV-1 Vaccine Test in Uninfected Adult Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT00009685 Org: User:
Start: 01/31/01 End: 03/31/05 Due: 03/31/06

Evaluating the Safety and Drug Levels of an Antibody Against HIV in Healthy, HIV-Uninfected Adults

Phase: N/A Priority: Normal
NCT ID: NCT02165267 Org: User:
Start: 08/31/14 End: 02/29/16 Due: 02/28/17

Safety and Pharmacokinetics of a Single ZMappTM Administration in Healthy Adult Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02389192 Org: User:
Start: 03/11/15 End: 12/27/17 Due: 12/27/18

Vaccine for Prevention of Bird Flu

Phase: N/A Priority: Normal
NCT ID: NCT00776711 Org: User:
Start: 10/16/08 End: 01/14/11 Due: 01/14/12

Safety and Tolerability of AAV8 Delivery of a Broadly Neutralizing Antibody in Adults Living With HIV: a Phase 1, Dose-escalation Trial

Phase: N/A Priority: Normal
NCT ID: NCT03374202 Org: User:
Start: 01/11/18 End: 08/08/26 Due: 08/08/27